Latest Blogs

Guest Commentary
Mar 16, 2023
Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
Clear expectations are key for effective teamwork. Tammy Triglianos, Dr. Ethan Basch, and Dr. Matthew Milowsky share a guidance document to facilitate excellent collaboration in advanced practice provider/physician teams.
Guest Commentary
Mar 14, 2023
Geriatric Oncology: A Training Opportunity That Has Come of Age
Four geriatric oncology experts answer five questions about the field, including what oncology trainees need to know, how to pursue consolidated training, and why geriatric oncology is a meaningful and rewarding career.
International Perspectives
Mar 14, 2023
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
Dr. Khalid El Bairi was invited to participate in the International Summit of Health Professionals in Pakistan, a country he only knew from the news and nature documentaries. The visit challenged his perceptions and allowed him to make valuable connections.
Anees B. Chagpar, MD, MPH, MBA, MSc, MA, FACS, FRCS, FASCO
Mar 07, 2023
ASCO Multidisciplinary Cancer Management Course in Brazil Offers Practical Framework for Engaging Tumor Boards
I recently visited Porto Alegre, Brazil, for an ASCO Multidisciplinary Cancer Management Course. Reducing the global cancer burden is a formidable goal, but one to which ASCO is incredibly committed.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jul 16, 2018
Increasing Patient Inclusion in Cancer Clinical Trials: A Conversation With Dr. Edward S. Kim
Broadening eligibility critera for cancer clinical trials will give more patients the opportunity to contribute to scientific research.
Jul 09, 2018
Right-to-Try: A Conversation With Dr. Richard L. Schilsky
I am really pleased to have with us ASCO's Chief Medical Officer and Senior Vice President for a conversation focusing on right-to-try policies.
Jun 29, 2018
Highlights of May/June Board of Directors Meeting: Annual Meeting, Leadership Development Program
At the most recent Board of Directors meeting, we heard insightful presentations from participants in the Leadership Development Program, pivoted toward the execution of our 5-year strategic plan, and had a valuable conversation with NCI director Dr. Norman Sharpless.
2 Comments
May 24, 2018
Biosimilars: A Conversation With Dr. Gary H. Lyman
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 17, 2018
Changes to MOC: New Pathways for Assessment
ASCO would like to inform you of some changes to MOC that are a direct result of your input and our open, transparent collaboration with the ABIM. 
May 08, 2018
State Advocacy: A Conversation With Dr. Melissa S. Dillmon
We examine how state-level health care policy may impact the care that we deliver to our patients with cancer, and why it's important for us to pay attention to and help shape bills and regulations moving in states.

Pages